MOREPENLAB115.50

Morepen Laboratories Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersIOLCPINNOVACAPFDCORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹6,328 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,690.41,811.61,805.71,950.6
Other Income14.018.421.322.1
Total Income1,704.41,829.91,827.01,972.7
Expenses
+ Cost of Materials Consumed883.3999.21,043.11,133.8
+ Purchases of Stock-in-Trade177.0207.282.575.1
+ Changes in Inventories2.1-47.1-2.1-29.1
+ Employee Benefit Expense181.5208.9232.7239.9
+ Finance Costs3.78.316.417.2
+ Depreciation & Amortisation33.529.036.435.8
+ Other Expenses287.9269.3323.9346.9
Total Expenses1,569.01,674.81,732.91,819.6
EBITDA158.6174.1125.6184.0
EBIT125.2145.189.2148.2
Profit
PBT before Exceptional Items135.4155.194.1153.1
+ Exceptional Items0.00.025.825.8
Pretax Income135.4155.1119.9178.9
+ Current Tax39.232.415.830.3
+ Deferred Tax-0.44.78.58.0
Tax Expense38.837.124.338.3
+ Share of Associates & JVs-0.50.0-0.8-0.1
Net Income96.2118.094.9140.5
+ Net Income — Continuing Ops96.6118.095.6140.6
+ Other Comprehensive Income-1.80.36.25.8
Total Comprehensive Income94.3118.3101.1146.3
Per Share
Basic EPS1.882.201.732.56
Diluted EPS1.882.201.732.56
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs-0.50.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income0.36.25.8
+ Items NOT to be Reclassified to P&L-2.80.36.25.6
+ Tax on Items NOT to be Reclassified0.10.0-0.2
+ Tax on Items NOT to be Reclassified — alt tag-0.7
+ Items to be Reclassified to P&L0.20.1-0.0
+ Tax on Items to be Reclassified0.00.00.2
Per Share — as-filed variants
Basic EPS — Continuing Operations1.882.201.732.56
Diluted EPS — Continuing Operations1.882.201.732.56
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit628.0652.3682.3770.8
Gross Margin %37.1536.0137.7839.52
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)135.4155.194.1153.1
− Exceptional Items (reconciliation)0.00.025.825.8
Net Income Adj (tax-effected)96.2118.074.3120.2
EPS Adj1.882.201.352.19
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital102.2109.6109.6109.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.